Belldegrun Arie 4
4 · Allogene Therapeutics, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Belldegrun Arie
Director
Transactions
- Award
Stock Option (Right to buy)
2024-01-25+749,398→ 749,398 totalExercise: $3.20Exp: 2034-01-25→ Common Stock (749,398 underlying) - Award
Common Stock
2024-01-25+211,973→ 1,866,859 total
Holdings
- 1,798,163(indirect: See footnote)
Common Stock
- 4,710,120(indirect: See footnote)
Common Stock
- 195,039(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The securities are held by Vida Ventures LLC (Vida), of which VV Manager LLC is the manager. The reporting person is a Senior Managing Director of VV Manager LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- [F2]The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun
- [F3]The securities are held in the name of Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary
- [F4]1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter.